Two Sigma Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
TRCT
GS
MIG
CBU
AF
EFG
Two Sigma Securities's LABU Position: Q2 2026 in Review
Two Sigma Securities increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 18% in Q2 2026, buying an estimated $181K and bringing the position to 6,064 shares worth $1.77M. The position accounts for 0.15% of the portfolio, ranked #125.
Two Sigma Securities first reported a position in LABU in Q2 2016 and has held it in 13 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.
- Two Sigma Securities held 6,064 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.77M as of Q2 2026.
- Two Sigma Securities bought 944 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $181K.
- Direxion Daily S&P Biotech Bull 3X ETF made up 0.15% of Two Sigma Securities's portfolio in Q2 2026, its #125 holding.
- Two Sigma Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2016 and has held it in 13 quarters since.
- 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.